These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15655932)

  • 1. Overview of phase I/II pemetrexed studies.
    Hanauske AR; Dittrich C; Otero J
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):18-25. PubMed ID: 15655932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pemetrexed in advanced colorectal cancer.
    Louvet C; de Gramont A
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):56-62. PubMed ID: 15655939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II studies of pemetrexed in metastatic breast and gynecologic cancers.
    Smith I
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):63-5. PubMed ID: 15655940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemetrexed: its promise in treating non-small-cell lung cancer.
    Manegold C
    Oncology (Williston Park); 2004 Jul; 18(8 Suppl 5):43-8. PubMed ID: 15339059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemetrexed: single-agent and combination phase I study overview.
    Boyer MJ; Rivory LP; Clarke SJ
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):18-23. PubMed ID: 12571806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-dependent administration of raloxifene and 5-fluorouracil/pemetrexed protects against pemetrexed cytotoxicity in human bone marrow.
    Das JR; Fryar-Tita EB; Green S; Southerland WM; Bowen D
    Anticancer Res; 2007; 27(2):825-33. PubMed ID: 17465208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent.
    Adjei AA
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4276s-4280s. PubMed ID: 15217974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemetrexed in front-line chemotherapy for advanced non-small-cell lung cancer.
    Scagliotti GV; Novello S; Crino L; Rosell R
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):32-7. PubMed ID: 15655934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancer.
    Clarke SJ; Boyer MJ; Millward M; Underhill C; Moylan E; Yip D; White S; Childs A; Beale P; Latz J; Suri A; Iglesias JL
    Lung Cancer; 2005 Sep; 49(3):401-12. PubMed ID: 15923057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine and Pemetrexed disodium in treating breast cancer.
    Adjei AA
    Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):34-7. PubMed ID: 11252887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of phase I trials of multitargeted antifolate (MTA, LY231514).
    Rinaldi DA
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):82-8. PubMed ID: 10598560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief communication: use of the multitargeted antifolate pemetrexed (Alimta) in genitourinary cancer.
    Misset JL
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):36-9. PubMed ID: 11894006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts.
    Teicher BA; Chen V; Shih C; Menon K; Forler PA; Phares VG; Amsrud T
    Clin Cancer Res; 2000 Mar; 6(3):1016-23. PubMed ID: 10741729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemetrexed: an active new agent for breast cancer.
    O'Shaughnessy JA
    Semin Oncol; 2002 Dec; 29(6 Suppl 18):57-62. PubMed ID: 12571813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational research with pemetrexed in breast cancer.
    Hanauske AR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):66-9. PubMed ID: 15655941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemetrexed in malignant pleural mesothelioma.
    Gatzemeier U
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):26-31. PubMed ID: 15655933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Pemetrexed (Alimta , LY231514) in lung cancer therapy.
    Molina JR; Adjei AA
    Clin Lung Cancer; 2003 Jul; 5(1):21-7. PubMed ID: 14596699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemetrexed in transitional cell carcinoma of the urothelium.
    von der Maase H
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):48-50. PubMed ID: 15655937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemetrexed in pancreatic cancer.
    Seitz JF; Dahan L; Ries P
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):43-7. PubMed ID: 15655936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I trials of pemetrexed.
    Fossella FV; Gatzemeier U
    Semin Oncol; 2002 Apr; 29(2 Suppl 5):8-16. PubMed ID: 12023787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.